Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib

Ilario Giovanni Rapposelli, Toshifumi Tada, Shigeo Shimose, Valentina Burgio, Takashi Kumada, Hideki Iwamoto, Atsushi Hiraoka, Takashi Niizeki, Masanori Atsukawa, Hironori Koga, Masashi Hirooka, Takuji Torimura, Massimo Iavarone, Raffaella Tortora, Claudia Campani, Sara Lonardi, Emiliano Tamburini, Fabio Piscaglia, Gianluca Masi, Giuseppe CabibboFrancesco Giuseppe Foschi, Marianna Silletta, Kunihiko Tsuji, Toru Ishikawa, Koichi Takaguchi, Kazuya Kariyama, Ei Itobayashi, Kazuto Tajiri, Noritomo Shimada, Hiroshi Shibata, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Shinya Fukunishi, Hideko Ohama, Kazuhito Kawata, Joji Tani, Shinichiro Nakamura, Kazuhiro Nouso, Akemi Tsutsui, Takuya Nagano, Takaaki Tanaka, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Francesca Ratti, Luca Aldrighetti, Stefano Cascinu, Andrea Casadei-Gardini

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib'. Together they form a unique fingerprint.

Medicine & Life Sciences